Reports Q1 revenue $62.55M vs $27.44M last year.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ARWR:
- Arrowhead options imply 5.6% move in share price post-earnings
- Arrowhead initiates Phase 1/2a study of ARO-MMP7 to treat PF
- Cantor Fitzgerald biotech analyst to hold analyst/industry conference call
- Arrowhead price target lowered to $60 from $82 at Chardan
- Arrowhead price target lowered to $55 from $64 at Piper Sandler